43 completed, 11 terminated, 6 unknown, 4 active not recruiting. 70 Phase 2, 16 Phase 1, 3 Phase 3.
Follow Radiotherapy, Conformal: new trials by email Literature Review of Radiotherapy, Conformal trials Research Report on Radiotherapy, Conformal
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin Lymphoma 3-Dimensional Conformal Radiation Therapy, Autologous Hematopoietic Stem Cell Transplantation, Biospecimen Collection - Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma | Phase 2 / Phase 3 | Not yet recruiting | National Cancer Institute (NCI) | 374 | 2026-12-04 | 2026-07-08 |
| A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma 3-Dimensional Conformal Proton Radiation Therapy, 3-Dimensional Conformal Radiation Therapy, Biospecimen Collection - Basal Ganglia Germinoma, Diabetes Insipidus | Phase 2 | Recruiting | Children's Oncology Group | 240 | 2024-10-22 | 2026-08-25 |
| Propranolol With Chemotherapy or Chemoradiation for Esophageal Adenocarcinoma Carboplatin, 3 Dimensional Conformal Radiation Therapy, Propranolol - Esophageal Adenocarcinoma | Phase 2 | Recruiting | Roswell Park Cancer Institute | 106 | 2021-04-01 | 2026-10-22 |
| Single Fraction or Multi-fraction Palliative Radiation Therapy for the Improvement of Quality of Life in Patients With Metastatic Gynecologic Cancers 3-Dimensional Conformal Radiation Therapy, Intensity-Modulated Radiation Therapy, Quality-of-Life Assessment - Metastatic Malignant Female Reproductive System Neoplasm | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 28 | 2021-01-11 | 2026-10-30 |
| A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL) 3-Dimensional Conformal Radiation Therapy, Asparaginase Erwinia chrysanthemi, Biospecimen Collection - Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia | Phase 2 | Recruiting | National Cancer Institute (NCI) | 461 | 2020-12-17 | 2026-09-01 |
| Phase II Concurrent Durvalumab and Radiotherapy for for Stage III Non-Small Cell Lung Cancer Thoracic RT and Durvalumab, Consolidative Durvalumab - Non Small Cell Lung Cancer, Lung Cancer Stage III | Phase 2 | Completed | University of Texas Southwestern Medical Center | 10 | 2020-04-03 | 2025-03-21 |
| A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradiation Paclitaxel, Carboplatin, Dexamethasone - Gastric Cancer, Stomach Cancer | Phase 2 | Unknown | Icahn School of Medicine at Mount Sinai | 29 | 2018-12-03 | 2023-11-14 |
| Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer 3-Dimensional Conformal Radiation Therapy (3D-CRT), Docetaxel, Gemcitabine - Recurrent Non-Small Cell Lung Carcinoma, Stage IV Non-Small Cell Lung Cancer | Phase 2 | Active not recruiting | NRG Oncology | 218 | 2017-04-07 | 2026-06-08 |
| Clinical Trial Comparing Dose-intensified SBRT With Conventional Radiation Therapy for Spinal Metastases dose-intensified image-guided SBRT using simultaneous integrated boost, External 3-dimensional conformal radiotherapy (3D-CRT) - Spinal Metastasis | Phase 2 | Completed | University of Zurich | 219 | 2016-07-08 | 2026-01-29 |
| Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer Three-Dimensional Conformal Radiation Therapy, Intensity-Modulated Radiation Therapy - Extensive Stage Small Cell Lung Carcinoma, Limited Stage Small Cell Lung Carcinoma | Phase 2 / Phase 3 | Completed | NRG Oncology | 418 | 2015-12-22 | 2026-07-10 |
| FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer FDG-PET, surgery, 5-FU - Adenocarcinoma of the Gastroesophageal Junction, Gastric Adenocarcinoma | Phase 2 | Terminated | Alliance for Clinical Trials in Oncology | 5 | 2015-11-12 | 2025-01-20 |
| Pembrolizumab and Stereotactic Body Radiation Therapy or Non-Stereotactic Wide-Field Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer 3-Dimensional Conformal Radiation Therapy, Intensity-Modulated Radiation Therapy, Laboratory Biomarker Analysis - Malignant Solid Neoplasm, Metastatic Lung Non-Small Cell Carcinoma | Phase 1 / Phase 2 | Completed | M.D. Anderson Cancer Center | 124 | 2015-09-17 | 2026-05-15 |
| A Study of Accelerated 3 Fraction Photon,Proton or Brachytherapy for Early Invasive and Noninvasive Breast Ca Brachytherapy APBI, 3D-CRT (photon) APBI, Proton APBI - Breast Cancer | Phase 2 | Completed | Mayo Clinic | 170 | 2015-06-16 | 2024-09-19 |
| Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery hypofractionated radiation therapy, cisplatin, etoposide - Recurrent Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer | Phase 2 | Completed | Ohio State University Comprehensive Cancer Center | 21 | 2015-06-08 | 2025-06-12 |
| An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma 16 weeks of VEC + CDDP, VEC + HD-MTX, Chemotherapy + Valproate - Childhood Ependymoma | Phase 2 / Phase 3 | Recruiting | Centre Leon Berard | 536 | 2015-06-02 | 2024-04-26 |
| Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer Radiation Therapy, Carboplatin, Metformin - Adenosquamous Lung Carcinoma, Bronchioloalveolar Carcinoma | Phase 2 | Completed | NRG Oncology | 170 | 2014-08-01 | 2026-07-13 |
| RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE Omaveloxolone Lotion 0.5%, Omaveloxolone Lotion 3%, Vehicle Lotion - Breast Cancer | Phase 2 | Completed | Biogen | 187 | 2014-06-30 | 2025-06-03 |
| Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer Paclitaxel, Carboplatin, 3-Dimensional Conformal Radiation Therapy - Endometrial Serous Adenocarcinoma, Stage IIIA Uterine Corpus Cancer | Phase 2 | Terminated | Albert Einstein College of Medicine | 4 | 2014-04-10 | 2023-08-29 |
| Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer Radiation Therapy, Carboplatin, Cisplatin - Stage III Non-Small Cell Lung Cancer AJCC v7, Stage IIIA Non-Small Cell Lung Cancer AJCC v7 | Phase 2 | Terminated | National Cancer Institute (NCI) | 59 | 2013-11-04 | 2019-08-05 |
| High or Standard Intensity Radiation Therapy After Gemcitabine Hydrochloride and Nab-paclitaxel in Treating Patients With Pancreatic Cancer That Cannot Be Removed by Surgery low intensity radiation therapy, Capecitabine, Gemcitabine - Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer | Phase 2 | Terminated | Radiation Therapy Oncology Group | 20 | 2013-08-01 | 2018-07-13 |
Showing 20 of 70. Sign in to see all of them.
Carcinoma, Non-Small-Cell Lung (11) · Gliosarcoma (8) · Glioblastoma (7) · Squamous Cell Carcinoma of Head and Neck (6) · Head and Neck Neoplasms (5) · Lung Neoplasms (5) · Pancreatic Neoplasms (5) · Brain Neoplasms (4) · Neoplasm Metastasis (4) · Adenocarcinoma of Lung (3) · Astrocytoma (3) · Breast Neoplasms (3) · Central Nervous System Neoplasms (3) · Liver Neoplasms (3) · Prostatic Neoplasms (3)
National Cancer Institute (NCI) (13) · Radiation Therapy Oncology Group (9) · Children's Oncology Group (4) · M.D. Anderson Cancer Center (3) · NRG Oncology (3) · Fudan University (2) · Swiss Cancer Institute (2) · UNC Lineberger Comprehensive Cancer Center (2) · University of Washington (2) · Albert Einstein College of Medicine (1) · Alliance for Clinical Trials in Oncology (1) · Biogen (1) · Cancer Trials Ireland (1) · Case Comprehensive Cancer Center (1) · Centre Leon Berard (1)
United States (55) · Canada (15) · Australia (6) · Switzerland (6) · China (3) · Puerto Rico (3) · United Kingdom (3) · Belgium (2) · Ireland (2) · Israel (2) · Netherlands (2) · New Zealand (2) · Saudi Arabia (2) · Austria (1) · Czechia (1)
Oliver Sartor, MD (2) · Adam P. Dicker, MD, PhD (1) · Alessio G Morganti, Professor (1) · Alex Adjei (1) · Alexander Colevas (1) · Anurag Singh, MD (1) · C. Leland Rogers, MD (1) · ChaoSu HU, M.D. (1) · Chaosu Hu, MD (1) · Christina Tsien (1) · Christopher H. Crane, MD (1) · ChunYing Shen, M.D. (1) · Cristina P. Rodriguez, MD (1)
PMID 10661346, PMID 11208820, PMID 12694838, PMID 14529764, PMID 14967428, PMID 14967461, PMID 15142632, PMID 15590164, PMID 1584260, PMID 15936549, PMID 16467544, PMID 18955445, PMID 19577865, PMID 20381270, PMID 20598811, PMID 21377288, PMID 21414514, PMID 22178121, PMID 22342302, PMID 22633552, PMID 22673726, PMID 23045594, PMID 23139259, PMID 23460709, PMID 23474363, PMID 24064970, PMID 25057165, PMID 25105369, PMID 25832688, PMID 25964250, PMID 26328939, PMID 26493095, PMID 26561342, PMID 27497804, PMID 27701653, PMID 28086942, PMID 28984517, PMID 31386061, PMID 31545689, PMID 31786276, PMID 31996395, PMID 32009149, PMID 33051340, PMID 33096027, PMID 33560478, PMID 33571520, PMID 33608212, PMID 34323922, PMID 34632876, PMID 34749885
U10CA021661 (6), U10CA180868 (6), U10CA180886 (4), U10CA025224 (3), U10CA098543 (3), U10CA027469 (2), U10CA032102 (2), U10CA180821 (2), K12CA086913 (1), N01CM62209 (1), P30CA012197 (1), P30CA013330 (1), P30CA043703 (1), U01CA081457 (1), U10CA180820 (1)